A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19
第二代口服SARS-CoV-2主蛋白酶抑制剂：COVID-19治疗的临床候选药物
期刊:Journal of Medicinal Chemistry
影响因子:6.8
doi:10.1021/acs.jmedchem.3c02469
Allerton, Charlotte M N; Arcari, Joel T; Aschenbrenner, Lisa M; Avery, Melissa; Bechle, Bruce M; Behzadi, Mohammad Amin; Boras, Britton; Buzon, Leanne M; Cardin, Rhonda D; Catlin, Natasha R; Carlo, Anthony A; Coffman, Karen J; Dantonio, Alyssa; Di, Li; Eng, Heather; Farley, Kathleen A; Ferre, Rose Ann; Gernhardt, Steven S; Gibson, Scott A; Greasley, Samantha E; Greenfield, Siennah R; Hurst, Brett L; Kalgutkar, Amit S; Kimoto, Emi; Lanyon, Lorraine F; Lovett, Gabrielle H; Lian, Yajing; Liu, Wei; Martínez Alsina, Luis A; Noell, Stephen; Obach, R Scott; Owen, Dafydd R; Patel, Nandini C; Rai, Devendra K; Reese, Matthew R; Rothan, Hussin A; Sakata, Sylvie; Sammons, Matthew F; Sathish, Jean G; Sharma, Raman; Steppan, Claire M; Tuttle, Jamison B; Verhoest, Patrick R; Wei, Liuqing; Yang, Qingyi; Yurgelonis, Irina; Zhu, Yuao
